Thrombolytic Activity, Drug Likeness Property and ADME/T Analysis of Isolated Phytochemicals from Ginger (Zingiber officinale) Using In Silico Approaches
This experiment has been carried out to observe the potential thrombolytic activity of naturally occuring phytochemicals in Ginger (Zingiber officinale) and to analyze their drug likeness property and ADME/T profile. Thrombolytic activity of Ginger has already been confirmed in laboratory experiment and this study focuses on the molecular interactions among four phytocompounds (Isovanillin, Gingerol, Beta-sitosterol and 2,6-Dimethyl-2-octene-1,8-diol) found in Ginger and Tissue Plasminogen Activator (tPA). Present experiment is largely based on computer-aided drug design protocol where the strength of interaction is described as binding energy function. Isovanillin exhibited better docking score, and so this compound might have greater thrombolytic activity than others. Moreover, Isovanillin also suggested sound drug likeness property and ADME/T profile which predicts its safeness for consumption in human body. But Beta-sitosterol violated Lipinski’s rule of five and 2, 6-Dimethyl-2-octene-1,8-diol showed the lowest affinity of binding with tPA. However, further in vivo or in vitro study may be required to confirm the thrombolytic activity of Isovanillin.
References
[1]
Mackman, N. (2008) Triggers, Targets and Treatments for Thrombosis. Nature, 451, 914-918. https://doi.org/10.1038/nature06797
[2]
Silberberg, M. (1938) The Causes and Mechanism of Thrombosis. Physiological Reviews, 18, 197-228. https://doi.org/10.1152/physrev.1938.18.2.197
[3]
Bick, R.L. and Kaplan, H. (1998) Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Causes of Thrombosis. Medical Clinics of North America, 82, 409-458. https://doi.org/10.1016/S0025-7125(05)70004-3
[4]
Daley, M.J., Murthy, M.S. and Peterson, E.J. (2015) Bleeding Risk with Systemic Thrombolytic Therapy for Pulmonary Embolism: Scope of the Problem. Therapeutic Advances in Drug Safety, 6, 57-66. https://doi.org/10.1177/2042098615572333
[5]
Liao, Y.R., Leu, Y.L., Chan, Y.Y., Kuo, P.C. and Wu, T.S. (2012) Anti-Platelet Aggregation and Vasorelaxing Effects of the Constituents of the Rhizomes of Zingiber officinale. Molecules, 17, 8928-8937. https://doi.org/10.3390/molecules17088928
[6]
Akram, M. and Rashid, A. (2017) Anti-Coagulant Activity of Plants: Mini Review. Journal of Thrombosis and Thrombolysis, 44,406-411.
https://doi.org/10.1007/s11239-017-1546-5
[7]
Riaz, H., Begum, A., Raza, S.A., Khan, Z.M.U.D., Yousaf, H. and Tariq, A. (2015) Antimicrobial Property and Phytochemical Study of Ginger Found in Local Area of Punjab, Pakistan. International Current Pharmaceutical Journal, 4, 405-409.
https://doi.org/10.3329/icpj.v4i7.23591
[8]
Ali, B.H., Blunden, G., Tanira, M.O. and Nemmar, A. (2008) Some Phytochemical, Pharmacological and Toxicological Properties of Ginger (Zingiber officinale Roscoe): A Review of Recent Research. Food and Chemical Toxicology, 46, 409-420.
https://doi.org/10.1016/j.fct.2007.09.085
[9]
Chapin, J.C. and Hajjar, K.A. (2015) Fibrinolysis and the Control of Blood Coagulation. Blood Reviews, 29, 17-24. https://doi.org/10.1016/j.blre.2014.09.003
[10]
Lin, L. and Hu, K. (2014) Tissue Plasminogen Activator: Side Effects and Signaling. Journal of Drug Design and Research, 1, 1001.
Collen, D. and Lijnen, H.R. (2009) The Tissue-Type Plasminogen Activator Story. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 1151-1155.
https://doi.org/10.1161/ATVBAHA.108.179655
[13]
Pannell, R., Black, J. and Gurewich, V. (1988) Complementary Modes of Action of Tissue-Type Plasminogen Activator and Pro-Urokinase by Which Their Synergistic Effect on Clot Lysis May Be Explained. The Journal of Clinical Investigation, 81, 853-859. https://doi.org/10.1172/JCI113394
[14]
Nordenhem, A. and Wiman, N.B. (1998) Tissue Plasminogen Activator (tPA) Antigen in Plasma: Correlation with Different tPA/Inhibitor Complexes. Scandinavian Journal of Clinical and Laboratory Investigation, 58, 475-484.
https://doi.org/10.1080/00365519850186274
[15]
Zoete, V., Grosdidier, A. and Michielin, O. (2009) Docking, Virtual High Throughput Screening and in Silico Fragment-Based Drug Design. Journal of Cellular and Molecular Medicine, 13, 238-248.
https://doi.org/10.1111/j.1582-4934.2008.00665.x
[16]
de Ruyck, J., Brysbaert, G., Blossey, R. and Lensink, M.F. (2016) Molecular Docking as a Popular Tool in Drug Design, an in Silico Travel. Advances and Applications in Bioinformatics and Chemistry: AABC, 9, 1-11.
https://doi.org/10.2147/AABC.S105289
[17]
McInnes, C. (2007) Virtual Screening Strategies in Drug Discovery. Current Opinion in Chemical Biology, 11, 494-502. https://doi.org/10.1016/j.cbpa.2007.08.033
[18]
Ekins, S., Mestres, J. and Testa, B. (2007) In Silico Pharmacology for Drug Discovery: Applications to Targets and Beyond. British Journal of Pharmacology, 152, 21-37. https://doi.org/10.1038/sj.bjp.0707306
[19]
Release, S. (2018) 1: Maestro. Schrodinger, New York.
[20]
Biovia, D.S. (2019) Discovery Studio Visualizer. San Diego.
[21]
Spessard, G.O. (1998) ACD Labs/LogP dB 3.5 and ChemSketch 3.5. Journal of Chemical Information and Computer Sciences, 38, 1250-1253.
https://doi.org/10.1021/ci980264t
[22]
Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (1997) Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings. Advanced Drug Delivery Reviews, 23, 3-25.
https://doi.org/10.1016/S0169-409X(96)00423-1
[23]
Khan, A.A., Ashfaq, M. and Ali, M.N. (1979) Pharmacognostic Studies of Selected Idigenous Plants of Pakistan.
[24]
Ramjan, A., Hossain, M., Runa, J.F., Md, H. and Mahmodul, I. (2014) Evaluation of Thrombolytic Potential of Three Medicinal Plants Available in Bangladesh, as a Potent Source of Thrombolytic Compounds. Avicenna Journal of Phytomedicine, 4, 430.
[25]
Thomson, M., Al-Qattan, K.K., Al-Sawan, S.M., Alnaqeeb, M.A., Khan, I. and Ali, M. (2002) The Use of Ginger (Zingiber officinale Rosc.) as a Potential Anti-Inflammatory and Antithrombotic Agent. Prostaglandins, Leukotrienes and Essential Fatty Acids, 67, 475-478. https://doi.org/10.1054/plef.2002.0441
[26]
Shoichet, B.K., McGovern, S.L., Wei, B. and Irwin, J.J. (2002) Lead Discovery Using Molecular Docking. Current Opinion in Chemical Biology, 6, 439-446.
https://doi.org/10.1016/S1367-5931(02)00339-3
[27]
Hubbard, R.E. and Kamran Haider, M. (2001) Hydrogen Bonds in Proteins: Role and Strength. eLS. https://doi.org/10.1038/npg.els.0003011
[28]
Ursu, O., Rayan, A., Goldblum, A. and Oprea, T.I. (2011) Understanding Drug-Likeness. Wiley Interdisciplinary Reviews: Computational Molecular Science, 1, 760-781. https://doi.org/10.1002/wcms.52
[29]
Petit, J., Meurice, N., Kaiser, C. and Maggiora, G. (2012) Softening the Rule of Five—Where to Draw the Line? Bioorganic & Medicinal Chemistry, 20, 5343-5351.
https://doi.org/10.1016/j.bmc.2011.11.064
[30]
Leeson, P.D. and Springthorpe, B. (2007) The Influence of Drug-Like Concepts on Decision-Making in Medicinal Chemistry. Nature Reviews Drug Discovery, 6, 881.
https://doi.org/10.1038/nrd2445
[31]
Pollastri, M.P. (2010) Overview on the Rule of Five. Current Protocols in Pharmacology, 49, 9-12. https://doi.org/10.1002/0471141755.ph0912s49
[32]
Van De Waterbeemd, H. and Gifford, E. (2003) ADMET in Silico Modelling: Towards Prediction Paradise? Nature Reviews Drug Discovery, 2,192.
https://doi.org/10.1038/nrd1032
[33]
Ekins, S., Boulanger, B., Swaan, P.W. and Hupcey, M.A. (2002) Towards a New Age of Virtual ADME/TOX and Multidimensional Drug Discovery. Journal of Computer-Aided Molecular Design, 16, 381-401. https://doi.org/10.1023/A:1020816005910
[34]
Li, A.P. (2001) Screening for Human ADME/Tox Drug Properties in Drug Discovery. Drug Discovery Today, 6, 357-366.
https://doi.org/10.1016/S1359-6446(01)01712-3
[35]
Geerts, T. and Vander Heyden, Y. (2011) In Silico Predictions of ADME-Tox Properties: Drug Absorption. Combinatorial Chemistry & High Throughput Screening, 14, 339-361. https://doi.org/10.2174/138620711795508359
[36]
Anzenbacher, P. and Anzenbacherova, E. (2001) Cytochromes P450 and Metabolism of Xenobiotics. Cellular and Molecular Life Sciences CMLS, 58, 737-747.
https://doi.org/10.1007/PL00000897
[37]
Valerio Jr., L.G. (2009) In Silico Toxicology for the Pharmaceutical Sciences. Toxicology and Applied Pharmacology, 241, 356-370.
https://doi.org/10.1016/j.taap.2009.08.022
[38]
Dar, A.M. and Mir, S. (2017) Molecular Docking: Approaches, Types, Applications and Basic Challenges. Journal of Analytical and Bioanalytical Techniques, 8, 356.
https://doi.org/10.4172/2155-9872.1000356
